|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> Revumenib>> Market Analysis Reports |
Market Analysis Reports of Revumenib |
|
Global Menin Inhibitor Drugs Clinical Trials & Future Opportunity Insight 2023 ... most promising candidates currently. Revumenib was developed by Syndax Pharmaceuticals ... -101 clinical trials is assessing Revumenib as a monotherapy in acute leukemias and ... -102 clinical trial is testing Revumenib in combination with chemotherapy to determine ... Global Menin Inhibitors Drug Market, Price, Sales & Clinical Trials Insight 2028 ... with the October 2024 approval of revumenib (Revuforj) for KMT2A-rearranged AML ... |